Nutex Health (NASDAQ:NUTX) Stock Price Expected to Rise, Maxim Group Analyst Says

Nutex Health (NASDAQ:NUTX) had its target price hoisted by Maxim Group from $100.00 to $225.00 in a report released on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Maxim Group’s target price points to a potential upside of 33.14% from the company’s previous close.

Separately, Benchmark boosted their price target on Nutex Health from $150.00 to $300.00 and gave the company a “buy” rating in a research note on Thursday, May 15th.

Nutex Health Stock Down 4.6%

NUTX stock opened at $169.00 on Tuesday. The company has a market cap of $940.65 million, a PE ratio of -18.00 and a beta of -0.10. The business has a 50-day simple moving average of $109.34 and a 200 day simple moving average of $64.30. Nutex Health has a 52 week low of $4.16 and a 52 week high of $184.28. The company has a quick ratio of 1.74, a current ratio of 1.77 and a debt-to-equity ratio of 3.36.

Nutex Health (NASDAQ:NUTX) last posted its quarterly earnings results on Tuesday, May 13th. The company reported $2.56 EPS for the quarter, beating analysts’ consensus estimates of ($0.15) by $2.71. The business had revenue of $211.79 million during the quarter, compared to the consensus estimate of $81.09 million. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%.

Insider Buying and Selling at Nutex Health

In other Nutex Health news, CFO Jon Christian Bates bought 1,000 shares of the firm’s stock in a transaction on Tuesday, April 8th. The shares were purchased at an average price of $81.81 per share, for a total transaction of $81,810.00. Following the completion of the transaction, the chief financial officer now directly owns 4,888 shares in the company, valued at approximately $399,887.28. The trade was a 25.72% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Company insiders own 38.52% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Bank of America Corp DE grew its holdings in shares of Nutex Health by 6,590.3% during the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock worth $66,000 after purchasing an additional 2,043 shares during the last quarter. Northern Trust Corp bought a new stake in shares of Nutex Health during the fourth quarter worth about $200,000. Baader Bank Aktiengesellschaft bought a new stake in shares of Nutex Health during the fourth quarter worth about $206,000. Millennium Management LLC bought a new stake in shares of Nutex Health during the fourth quarter worth about $213,000. Finally, World Investment Advisors bought a new stake in shares of Nutex Health during the fourth quarter worth about $217,000. Institutional investors own 5.32% of the company’s stock.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.